PUBLICAÇÕES científicas

/cun/pt/investigacion/publicaciones-cientificas/areaMain/02
  • Modified inspiratory muscle training (m-IMT) as promising treatment for gastro-oesophageal reflux disease (GERD)

    Moffa A (1), Oliveto G (2), Matteo FD (3), Baptista P (4), Cárdenas A 5, Cassano M (5), Casale M (2)

    (1) Unit of Otolaryngology, University of Foggia, Foggia, Italy.
    (2) Unit of Otolaryngology, University Campus Bio-Medico, Rome, Italy.
    (3) Unit of Gastroenterology, University Campus Bio-Medico, Rome, Italy.
    (4) Unit of Otolaryngology, University of Navarra, Campus Universitario, Pamplona, Spain.
    (5) Unit of Otolaryngology, University of Foggia, Foggia, Italy.

    Acta Otorrinolaringologica Española 15 de MAIO de 2019

  • Management of common adverse events related to first-line dacomitinib use in EGFR mutation-positive non-small-cell lung cancer

    Zhou Q (1), Wu YL (1), Corral J (2), Nakagawa K (3), Garon EB (4), Sbar EI (5), Wang T (6), Sandin R (7), Noonan K (6), Gernhardt D (6), Mok TS (8).

    (1) Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China.
    (2) Clínica Universidad de Navarra, Madrid, 28027, Spain.
    (3) Kindai University Hospital, Osaka, 589-8511, Japan.
    (4) David Geffen School of Medicine, University of California at Los Angeles, Santa Monica, CA 90404, USA.
    (5) Pfizer Inc., Collegeville, PA 19426, USA.
    (6) Pfizer Inc., Groton, CT 06340, USA.
    (7) Pfizer Inc., Sollentuna, 191 38, Sweden.
    (8) State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China.

    Future Oncology 15 de MAIO de 2019

  • Melanocortin-4 Receptor and Lipocalin 2 Gene Variants in Spanish Children with Abdominal Obesity

    Morell-Azanza L (1,2), Ojeda-Rodríguez A (3,4), Giuranna J (5), Azcona-SanJulián MC (6,7), Hebebrand J (8), Marti A (9,10,11), Hinney A (12).

    (1) Department of Nutrition, Food Sciences and Physiology, University of Navarra, c/Irunlarrea, 1. 31008 Pamplona, Spain
    (2) IdiSNA, Instituto de Investigación Sanitaria de Navarra, c/Irunlarrea, 3. 31008, Pamplona , Spain
    (3) Department of Nutrition, Food Sciences and Physiology, University of Navarra, c/Irunlarrea, 1. 31008 Pamplona, Spain
    (4) IdiSNA, Instituto de Investigación Sanitaria de Navarra, c/Irunlarrea, 3. 31008, Pamplona , Spain
    (5) Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Virchowstr. 174, D-45147, Essen,Germany.
    (6) IdiSNA, Instituto de Investigación Sanitaria de Navarra, c/Irunlarrea, 3. 31008, Pamplona , Spain.
    (7) Paediatric Endocrinology Unit, Department of Paediatrics, Clínica Universidad de Navarra,c/ Pío XII, 36. 31008 Pamplona, Spain.
    (8) Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Virchowstr. 174, D-45147, Essen,Germany.
    (9) Department of Nutrition, Food Sciences and Physiology, University of Navarra, c/Irunlarrea, 1. 31008 Pamplona, Spain.
    (10) IdiSNA, Instituto de Investigación Sanitaria de Navarra, c/Irunlarrea, 3. 31008, Pamplona , Spain.
    (11) Biomedical Research Centre Network on Obesity and Nutrition (CIBERobn), Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Av. Monforte de Lemos, 3-5. 28029 Madrid, Spain
    (12) Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Virchowstr. 174, D-45147, Essen,Germany

    Nutrients 26 de ABRIL de 2019

  • Mannosylated nanoparticles for oral immunotherapy in a murine model of peanut allergy

    Brotons-Canto A (1), Gamazo C (1), Martín-Arbella N (1), Abdulkarim M (2), Gumbleton M (2), Quincoces G (3), Peñuelas I (3), Irache JM (4).

    (1) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.
    (2) School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, UK.
    (3) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Spain.
    (4) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.

    Journal of Pharmaceutical Sciences 05 de MARÇO de 2019

  • Metastatic tumors in the pancreas: the role of endoscopic ultrasound-guided fine-needle aspiration

    Betés M (1), González Vázquez S (2), Bojórquez A (3), Lozano MD (4), Echeveste JI (4), García Albarrán L (5), Muñoz Navas M (6), Súbtil JC (7).

    (1) Digestivo, Clinica Universidad de Navarra, España.
    (2) Aparato Digestivo, Clínica Universidad de Navarra-Madrid, España.
    (3) Aparato Digestivo, Clinica Universidad de Navarra, España.
    (4) Anatomía Patológica, Clínica Universidad de Navarra.
    (5) Aparato Digestivo, Hospital Virgen de la Concha.
    (6) Servicio de Aparato Digestivo, Clínica Universidad de Navarra.
    (7) Aparato Digestivo, Clínica Universidad de Navarra.

    Revista Española de Enfermedades Digestivas 11 de FEVEREIRO de 2019

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra